Market Snapshot

BSE Sensex: 73088.33 0.83%
BSE 500: 32199.48 0.32%
BSE 200: 10088.94 0.39%
BSE 100: 23199.58 0.55%
BSE Mid-Cap: 40004.52 -0.39%
BSE Small-Cap: 45433.79 -0.04%
BANKEX: 53720.76 1.02%
BSE IT Sector: 34139.78 -0.56%
Nifty 50: 22147 0.69%
Nifty 500: 20385.2 0.30%
Nifty 200: 12325.85 0.35%
Nifty 100: 22859.8 0.53%
Nifty Midcap 100: 48696.95 -0.61%
Nifty Small 100: 16270.4 -0.10%
Nifty IT: 33368.3 -0.39%
Nifty PSU Bank: 6933.25 -0.29%

News:

HDFC AMC Q4 PAT climbs 44% YoY...
Wipro Q4 PAT rises 5% QoQ to R...
Premier Explosives gains as bo...
Hindustan Zinc slides after Q4...
Axis Bank board to mull fund r...

Syncom Formulations (India) Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

19 Apr 2024 | 04:14 PM

12.55

-0.10 (-0.79%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

104.07%

Return (1Y)

Beaten Nifty 50 by 78.36%
More Volatile

3.59%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.96%
Consistent Performer

8/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

News & Announcements

Syncom Formulations (India) consolidated net profit rises 69.08% in the December 2023 quarter
63 days ago

Syncom Formulations (India) consolidated net profit rises 69.08% in the December 2023 quarter

16 - Feb - 2024 12:00 AM | 63 days ago

Net profit of Syncom Formulations (India) rose 69.08% to Rs 7.00 crore in the quarter ended December 2023 as against Rs 4.14 crore during the previous quarter ended December 2022. Sales rose 13.52% to Rs 65.14 crore in the quarter ended December 2023 as against Rs 57.38 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 65.14 57.38 14
OPM % 11.28 10.28 -
PBDT 10.83 7.17 51
PBT 9.38 5.97 57
NP 7.00 4.14 69
Powered by Capital Market - Live News
Syncom Formulations (India) to convene board meeting
72 days ago

Syncom Formulations (India) to convene board meeting

07 - Feb - 2024 12:00 AM | 72 days ago

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 14 February 2024.
Powered by Capital Market - Live News
Syncom Formulations (India) Ltd Spikes 5.22%
147 days ago

Syncom Formulations (India) Ltd Spikes 5.22%

24 - Nov - 2023 12:00 AM | 147 days ago

Syncom Formulations (India) Ltd rose 5.22% today to trade at Rs 13.31. The S&P BSE Healthcare index is up 0.82% to quote at 29821.15. The index is up 9.16 % over last one month. Among the other constituents of the index, Artemis Medicare Services Ltd increased 4.07% and Vijaya Diagnostic Centre Ltd added 3.07% on the day. The S&P BSE Healthcare index went up 26.41 % over last one year compared to the 6.06% surge in benchmark SENSEX.

Syncom Formulations (India) Ltd has added 67% over last one month compared to 9.16% gain in S&P BSE Healthcare index and 3.12% rise in the SENSEX. On the BSE, 8.53 lakh shares were traded in the counter so far compared with average daily volumes of 21.69 lakh shares in the past one month. The stock hit a record high of Rs 13.65 on 24 Nov 2023. The stock hit a 52-week low of Rs 4.55 on 28 Mar 2023.
Powered by Capital Market - Live News
Syncom Formulations (India) consolidated net profit rises 81.34% in the September 2023 quarter
162 days ago

Syncom Formulations (India) consolidated net profit rises 81.34% in the September 2023 quarter

09 - Nov - 2023 12:00 AM | 162 days ago

Net profit of Syncom Formulations (India) rose 81.34% to Rs 6.51 crore in the quarter ended September 2023 as against Rs 3.59 crore during the previous quarter ended September 2022. Sales rose 17.16% to Rs 63.84 crore in the quarter ended September 2023 as against Rs 54.49 crore during the previous quarter ended September 2022.
Particulars Quarter Ended
Sep. 2023 Sep. 2022 % Var.
Sales 63.84 54.49 17
OPM % 10.03 7.87 -
PBDT 9.33 6.54 43
PBT 8.45 5.36 58
NP 6.51 3.59 81
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Syncom Formulations (India) Ltd has increased by 26433.3% since past 3 Months
MF shareholding in Syncom Formulations (India) Ltd has increased by 16.67% since past 3 Months
MF shareholding in Syncom Formulations (India) Ltd has increased by 40% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2023	Dec. 2022	% Var.
Sales	65.14	57.38	14
OPM %	11.28	10.28	-
PBDT	10.83	7.17	51
PBT	9.38	5.97	57
NP	7.00	4.14	69

Particulars	Quarter Ended
	Sep. 2023	Sep. 2022	% Var.
Sales	63.84	54.49	17
OPM %	10.03	7.87	-
PBDT	9.33	6.54	43
PBT	8.45	5.36	58
NP	6.51	3.59	81

General Notifications

My Notifications

Research Notifications

Syncom Formulations (India) Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

12.55 -0.10 (-0.79%)

News & Announcements

Price vs Volume

Stock Trivia

Syncom Formulations (India) Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

12.55

-0.10 (-0.79%)